Evaluation of visual function and morphological changes in patients with adrenoleukodystrophy using SS-OCT and PVEP

Y F Yu, Lujie Zhang, Shuiqian Wen, Yu Li, Liang Tan, Xian Wu, Yangcheng Zou, Ting LiuDocumenta 2025 · DOI

Abstract: Adrenoleukodystrophy (ALD) patients often exhibit subclinical changes in retinal structure and visual pathway function. This study demonstrates that combining Sweep-Source Optical Coherence Tomography (SS-OCT) and Patterned Visual Evoked Potentials (PVEP) significantly improves the accuracy of early ALD diagnosis, providing a non-invasive method for monitoring neurodegeneration.

Introduction

Adrenoleukodystrophy (ALD) is a rare, X-linked neurodegenerative disease caused by mutations in the ABCD1 gene, leading to the toxic accumulation of very long-chain fatty acids (VLCFAs). This accumulation causes progressive demyelination of the central nervous system. Visual pathway involvement is a common early feature, yet traditional diagnostics like brain MRI and genetic testing are often too complex or expensive for routine monitoring. This research evaluates the synergy of structural and functional ocular biomarkers for early detection of ALD-driven neurodegeneration.

Methods and Materials

The study cohort included 46 ALD patients—approximately 80% of whom still had normal visual acuity—and 44 age-matched healthy controls. Researchers employed a dual-modality evaluation:

  1. SS-OCT (Sweep-Source Optical Coherence Tomography): High-resolution imaging used to quantify the thickness of the retinal nerve fiber layer (RNFL) and ganglion cell–inner plexiform layer (GCIPL) across standardized macular and peripapillary zones.
  2. PVEP (Patterned Visual Evoked Potentials): Electrophysiological assessment of the P100 wave to measure signal conduction speed (peak time) and strength (amplitude) in response to visual stimuli.
Standardized zones for SS-OCT measurements in the macula (A) and optic disc (B).

Results

The ALD group showed a significant delay in the P100 peak time, with a median of 113.6 ms compared to 107.2 ms in controls. Notably, signal amplitudes remained similar between groups, suggesting that early changes are primarily driven by demyelination rather than widespread axonal loss.

Morphologically, ALD patients exhibited significant thinning in the parafoveal GCIPL and RNFL. This thinning was highly localized, particularly affecting the superior and nasal quadrants of the parafoveal ring.

Comparison of GCIPL thickness in the S1 zone between ALD and control groups showing significant thinning (P=0.021).

A diagnostic model combining P100 peak time with specific structural metrics achieved an Area Under the Curve (AUC) of 0.883, with a sensitivity of 95%, significantly outperforming any single structural or functional metric used in isolation.

Discussion

The localized thinning in the superior and nasal parafoveal regions suggests that the papillomacular bundle—the nerve fibers responsible for central vision—is uniquely vulnerable to VLCFA-induced mitochondrial stress. The combination of structural thinning and functional signal delay provides a comprehensive view of early neurodegenerative changes. This dual-modality approach offers a promising, non-invasive tool for early diagnosis and for monitoring the efficacy of emerging treatments before irreversible damage occurs.

Conclusion

Integrating SS-OCT and PVEP metrics provides a highly sensitive diagnostic framework for ALD. By capturing subclinical neurodegeneration through both physical structure and electrical function, this approach facilitates earlier intervention and more precise disease management.

Summary updated

Abstract

ALD patients present with abnormal retinal structures and a PVEP peak time delay. Combining these two parameters could increase the accuracy of an early ALD diagnosis.
BibTeX
@inproceedings{yu2025evaluation,
  author = {Y F Yu and Lujie Zhang and Shuiqian Wen and Yu Li and Liang Tan and Xian Wu and Yangcheng Zou and Ting Liu},
  title = {{Evaluation of visual function and morphological changes in patients with adrenoleukodystrophy using SS-OCT and PVEP}},
  booktitle = {Documenta},
  year = {2025},
  doi = {10.1007/s10633-025-10021-6},
}
Figure